Search for instruments
bluebird bio Inc
Bluebird bio Inc is a biotech firm that specializes in developing gene therapies for severe genetic diseases and cancer. Their goal is to revolutionize the lives of patients with genetic disorders by providing them with innovative and effective treatments. Bluebird bio's gene therapy platform employs lentiviral vectors to deliver functional genes to patients' cells. Their flagship product, Zynteglo, is a gene therapy for beta-thalassemia, a rare blood disorder. Bluebird bio is also working on gene therapies for sickle cell disease, cerebral adrenoleukodystrophy, and multiple myeloma. The company is dedicated to advancing the field of gene therapy and enhancing the quality of life for patients with genetic diseases.Instrument specification in OANDA
Start trading now with fast account opening.
Sign-up now to trade the most active markets
Open account